Related Experiment Videos

EGF receptor signaling affects bcl-2 family gene expression and apoptosis after massive small bowel resection

Andrew W Knott1, Russell J Juno, Marcus D Jarboe

  • 1Division of Pediatric Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.

Abstract

Insights

Epidermal growth factor receptor (EGFR) signaling regulates enterocyte apoptosis after small bowel resection (SBR). Inhibiting EGFR accelerates apoptosis, while EGF promotes cell survival by altering bcl-2 family member expression.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Molecular Biology

Background:

  • Massive small bowel resection (SBR) increases enterocyte apoptosis.
  • Epidermal growth factor receptor (EGFR) signaling is inversely correlated with enterocyte apoptosis post-SBR.

Purpose of the Study:

  • To investigate how EGFR manipulation impacts bcl-2 family member expression in the context of SBR.

Main Methods:

  • Mice underwent 50% proximal SBR or sham operation.
  • Groups included control, exogenous EGF administration, and waved-2 mutant mice with defective EGFR signaling.
  • Apoptotic index and bax/bcl-w protein expression were assessed in the ileum.

Main Results:

  • Defective EGFR signaling in waved-2 mice significantly increased apoptosis post-SBR.
  • EGFR inhibition accelerated apoptosis and favored pro-apoptotic bcl-2 family members.
  • Exogenous EGF administration reduced apoptosis post-SBR by promoting cell survival.

Conclusions:

  • EGFR signaling critically regulates enterocyte apoptosis following SBR.
  • EGFR inhibition promotes apoptosis by altering bcl-2 family member expression.
  • Targeting EGFR may offer therapeutic strategies for managing SBR-induced enterocyte apoptosis.

Related Concept Videos